June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Rafael Fonseca: Discontinuation of lenalidomide maintenance based on MRD
Dec 9, 2024, 20:13

Rafael Fonseca: Discontinuation of lenalidomide maintenance based on MRD

Rafael Fonseca, Hematologist at Mayo Clinic, shared a post on X:

“Discontinuation of lenalidomide maintenance based on MRD status.

Most treated with triplets. A bit enriched for lower risk cases (by definition by being sustained MRD-).”

Rafael Fonseca

Dr. Rafael Fonseca, M.D., is a hematologist at Mayo Clinic, specializing in multiple myeloma and related conditions. Dr. Fonseca’s expertise extends to diagnosing and treating plasma cell disorders, leading clinical trials that have advanced myeloma treatment. He has led research on genetic markers in myeloma.

Dr. Fonseca has received numerous awards and honors, including the Damon Runyon-Walter Winchell Clinical Investigator Award and the International Waldenström Macroglobulinemia Research Award.